- Biden given clean bill of health (Miami Herald)
Joe Biden appears to be very healthy, with some routine aging issues. Also there's no evidence he has had a brain scan to completely rule out another aneurysm like the one that required emergency surgery 20 years ago.
- 96-Week Data From CASTLE Study Continue to Show Similar Efficacy Between Once-Daily REYATAZ(R) (atazanavir ... (wallstreet:online AG)
Bristol-Myers Squibb Company (NYSE: BMY) today announced 96-week data from the CASTLE study, in which
- Medical costs still burden many despite insurance (Boston Globe)
Although far more Massachusetts residents have health insurance coverage than residents nationwide, a significant portion of Bay Staters are still struggling to pay for needed healthcare, a new survey shows.
- Biden releases medical records (The News Journal)
WASHINGTON -- Joe Biden appears to be very healthy, with some routine aging issues, but there's no evidence he's had a brain scan to completely rule out another aneurysm like the one that required emergency surgery 20 years ago.
- Joe Biden appears to be in good health, records show (Los Angeles Times)
Biden's health records are released and indicate normal signs of aging. Although he had a brain aneurysm that required surgery 20 years ago, there is no sign that he is at risk of another aneurysm. WASHINGTON -- Joe Biden appears in very good health, with some of the routine issues of aging, but there's no evidence that he has had a brain scan to rule out completely another aneurysm like the ...
- 96-Week Data From CASTLE Study Continue to Show Similar Efficacy Between Once-Daily REYATAZ(R) (atazanavir ... (Business Wire via Yahoo! Finance)
PRINCETON, N.J.----Bristol-Myers Squibb Company today announced 96-week data from the CASTLE study, in which 74 percent of the 440 patients in the REYATAZ® /r arm achieved an undetectable viral load, defined as HIV-1 RNA less than 50 copies/mL, compared with 68 percent of the 443 patients in the lopinavir/r arm.